Healthcare & Medical Devices Global On demand · 24-48h

Global Gamma Camera Market Strategic Research Report

Global Gamma Camera Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gamma Camera Market
$1.78B2025
5.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sodium Iodide Crystal Cameras, Cadmium Zinc Telluride Semiconductor Cameras, Cesium Iodide High Sensitivity Cameras

By Application: Thyroid Scanning, Molecular Breast Imaging, Kidney Scanning, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: GE HealthCare Technologies Inc., Siemens Healthineers AG, Philips Healthcare, United Imaging Healthcare Co., Ltd., Spectrum Dynamics Medical, Mediso Medical Imaging Systems, Digirad Corporation, DDD-Diagnostic A/S

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 99 pages
Market size 2025
$1.78B
Billion USD
Forecast CAGR
5.8%
2025-2032
Forecast 2032
$2.6B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Gamma Camera market size is predicted to grow from US$ 1,784 million in 2025 to US$ 2,644 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

A gamma camera is strictly defined as a core medical imaging equipment that utilizes the principle of radioactive nuclide internal tracing. It intercepts and locates the single photon gamma rays introduced into the patient's body through a collimator, and converts them into electrical signals using scintillation crystals, photodetector arrays, and circuitry that conforms to the requirements. Finally, it reconstructs them into two-dimensional or three-dimensional molecular images reflecting the physiological functions and metabolic abnormalities of organs. This specialized product focuses on single photon imaging systems with sodium iodide crystals or cadmium zinc telluride semiconductors as the core, excluding more extensive positron emission tomography scanners, medical linear accelerators, traditional non-radioactive medical conventional ultrasound and diagnostic computed tomography scanner chassis. Its upstream supply chain consists of high-purity sodium iodide scintillation crystals, high-sensitivity photomultiplier tubes, high-density high-purity lead or tungsten collimators, cadmium zinc telluride semiconductor detection chips, high-precision radioactive source strength calibration modules, and multi-axis nuclear medicine dedicated cranes. The midstream is medical imaging equipment manufacturing enterprises with precise circuit design capabilities, high dynamic reconstruction algorithm development, radiation shielding packaging, and the integration of nuclear medicine multimodal fusion systems. The downstream precisely connects to the nuclear medicine departments of tertiary first-class general hospitals, radiation diagnosis centers of cancer specialized hospitals, cardiovascular disease clinical research institutes, pharmaceutical companies' new radioactive drug research and development centers, and independent medical imaging third-party testing institutions. In 2025, the global market average price of this specialized market is $380,000 per unit; the global annual sales volume is 4,800 units; the global total production capacity is approximately 6,100 units. The core production capacity is highly concentrated in the United States, China, Germany, the Netherlands, and Israel; the industry average profit margin, due to the extremely high nuclear medical entry threshold and complex photoelectric reconstruction algorithm barriers, maintains an overall weighted profit margin of approximately 27.5%.

The future trend of the gamma camera market is accelerating towards "teledyne cadmium zinc telluride solid-state semiconductorization" and "full digital artificial intelligence-assisted lesion reconstruction". To address the industry pain points of traditional photomultiplier tubes, which are large in size, have low energy resolution, and suffer from geometric distortion, digital detectors based on new semiconductor chips are replacing traditional scintillation crystals comprehensively. At the same time, combined with deep learning algorithms, they reduce noise and eliminate artifacts from weak phototransmission signals, achieving ultra-high-definition capture of extremely early tiny tumor lesions. The driving factors for market development mainly include: Firstly, the rapid increase in the base of patients with malignant tumors, neurological disorders such as cognitive impairment, and myocardial ischemia due to the intensification of global population aging directly drives the rigid clinical demand for nuclear medicine molecular imaging screening; Secondly, the accelerated research and approval of new targeted radiopharmaceuticals and their coupling with radionuclides have made "diagnosis and treatment integration" the core development direction of hospital oncology departments, greatly stimulating the expansion and procurement of matching high-precision gamma imaging equipment by downstream hospitals; Finally, the upgrading and policy inclination of the construction standards for nuclear medicine departments in county-level general hospitals and regional medical centers in major countries have injected stable and continuous grassroots-level update and growth increments into this specialized equipment market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gamma Camera market?

What factors are driving Gamma Camera market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gamma Camera market opportunities vary by end market size?

How does Gamma Camera break out by Type, by Application?

This report presents a comprehensive overview of the global Gamma Camera market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Sodium Iodide Crystal Cameras
  • Cadmium Zinc Telluride Semiconductor Cameras
  • Cesium Iodide High Sensitivity Cameras

Segment by Modality Fusion

  • Planar Scintigraphy Single Systems
  • Single Photon Emission Computed Tomography Systems
  • Hybrid Spect Hybrids Systems

Segment by Scale

  • Large Scale Medical Gantry Cameras
  • Handheld Bedside Care Cameras
  • Dedicated Diagnostic Cameras

Segment by Application

  • Thyroid Scanning
  • Molecular Breast Imaging
  • Kidney Scanning
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gamma Camera market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Thyroid Scanning, Molecular Breast Imaging, Kidney Scanning evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Gamma Camera Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.78B
2025
Forecast
$2.6B
2032
CAGR
5.8%
2025–2032
Regiões
5
global
Key companies
GE HealthCare Technologies Inc.Siemens Healthineers AGPhilips HealthcareUnited Imaging Healthcare Co., Ltd.Spectrum Dynamics MedicalMediso Medical Imaging SystemsDigirad CorporationDDD-Diagnostic A/S
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Sodium Iodide Crystal CamerasCadmium Zinc Telluride Semiconductor CamerasCesium Iodide High Sensitivity Cameras
By Application
Thyroid ScanningMolecular Breast ImagingKidney ScanningOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Sodium Iodide Crystal Cameras
  • 3.1.3 Cadmium Zinc Telluride Semiconductor Cameras
  • 3.1.4 Cesium Iodide High Sensitivity Cameras
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Thyroid Scanning
  • 4.1.3 Molecular Breast Imaging
  • 4.1.4 Kidney Scanning
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GE HealthCare Technologies Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Siemens Healthineers AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Philips Healthcare
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 United Imaging Healthcare Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Spectrum Dynamics Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Mediso Medical Imaging Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Digirad Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 DDD-Diagnostic A/S
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Gamma Camera market?
The global Gamma Camera market is estimated at US$ 1.78 billion in 2025 (base year) and is projected to reach US$ 2.64 billion by 2032.
How fast is the Gamma Camera market expected to grow?
The market is expected to grow at a CAGR of 5.8% from 2026 to 2032, expanding from US$ 1.78 billion in 2025 to US$ 2.64 billion in 2032, roughly 1.5 times its base-year value.
What does the Gamma Camera market cover?
A gamma camera is strictly defined as a core medical imaging equipment that utilizes the principle of radioactive nuclide internal tracing. It intercepts and locates the single photon gamma rays introduced into the patient's body through a collimator, and converts them into electrical signals using scintillation crystals, photodetector arrays, and circuitry that conforms to the requirements.
What are the main segments of the Gamma Camera market by type?
By type, the market is segmented into Sodium Iodide Crystal Cameras, Cadmium Zinc Telluride Semiconductor Cameras and Cesium Iodide High Sensitivity Cameras.
Which applications drive demand in the Gamma Camera market?
Key applications covered include Thyroid Scanning, Molecular Breast Imaging, Kidney Scanning and Others.
Who are the key players in the Gamma Camera market?
Key players profiled include GE HealthCare Technologies Inc., Siemens Healthineers AG, Philips Healthcare, United Imaging Healthcare Co., Spectrum Dynamics Medical, Mediso Medical Imaging Systems, Digirad Corporation and DDD-Diagnostic A/S.
Which regions and countries are covered for Gamma Camera?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Gamma Camera market?
What factors are driving Gamma Camera market growth, globally and by region?
What challenges does the Gamma Camera market face?
The core production capacity is highly concentrated in the United States, China, Germany, the Netherlands, and Israel; the industry average profit margin, due to the extremely high nuclear medical entry threshold and complex photoelectric reconstruction algorithm barriers, maintains an overall weighted profit margin of approximately 27.5%.
Who should buy the Gamma Camera market report?
The report is intended for manufacturers and solution providers, distributors and end users in Thyroid Scanning, Molecular Breast Imaging and Kidney Scanning, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gamma Camera market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.